Clinical Trial Update: ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial of ABI-007 for inoperable locally recurrent or metastatic melanoma has completed. The update notes the study status, but detailed results are not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ABI-007 (nab-paclitaxel)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED